Related Experiment Video
Updated: Jan 6, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Tailoring a rapid autopsy protocol to explore cancer evolution: a patient collaboration
Cherie Blenkiron1, Tamsin Robb2, Kate Parker3
1Senior Research Fellow, Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland; The Maurice Wilkins Centre for Biodiscovery, The University of Auckland, Auckland.
New Zealand
Area of Science:
- Oncology
- Genomics
- Bioethics
Background:
- Genomic analysis of cancer tissues from rapid autopsy programs has advanced cancer research.
- Such programs are not yet established in New Zealand.
- A neuroendocrine tumour research group, NETwork!, received a patient's post-mortem tissue donation request.
Purpose of the Study:
- To outline the ethical, logistical, and social considerations for accepting a post-mortem tumour tissue donation.
- To highlight the scientific and educational benefits of such donations for cancer research in New Zealand.
Main Methods:
- Review of ethical guidelines and protocols for post-mortem tissue donation.
- Discussion of logistical challenges in tissue preservation and transport.
- Analysis of social implications and patient engagement.
Main Results:
- A comprehensive process for accepting the patient's donation was successfully navigated.
- The donation underscores the potential for valuable cancer research using post-mortem tissues.
- Established protocols can facilitate future donations.
Conclusions:
- Accepting post-mortem tumour donations is feasible and ethically sound.
- Such donations offer significant scientific and educational value for advancing cancer research in New Zealand.
- This case sets a precedent for future tissue procurement.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023